LYRINEX CR 165 mg contains Pregabalin Controlled Release 165 mg. It is an anticonvulsant and neuropathic pain medicine used to treat nerve pain by reducing abnormal nerve signals. The controlled-release formulation provides gradual release of the medicine for prolonged effect.
Uses:
-
Treatment of neuropathic (nerve) pain associated with diabetic peripheral neuropathy
-
Management of postherpetic neuralgia (nerve pain following shingles)
-
Treatment of other chronic neuropathic pain conditions as prescribed
Dose:
-
Adults: Usually 165 mg once daily after the evening meal, or as directed by a physician
-
Swallow the controlled-release tablet whole; do not crush, chew, or split
-
Dose may be adjusted according to the patient's response and kidney function
-
Do not stop the medicine suddenly without medical advice
-
Use under the supervision of a healthcare professional